Vidarabine

A nucleoside antibiotic and antiviral.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
3
AI-suggested references
0
Clinical trials

General information

Vidarabine on PubChem


Marketed as

VIRA-A

 

Structure image - Vidarabine

C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N


Supporting references

Link Tested on Impact factor Notes Publication date
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
Spike protein ACE2 Small molecule In silico
in silico 2.08

Predicted to inhibit the interaction between the SARS-CoV-2 spike protein domain S1 and the host ACE2 receptor.

Aug/21/2020

AI-suggested references